by Jordana Choucair | Jan 20, 2023 | Life Sciences
The Food and Drug Administration (FDA) rejected Eli Lilly & Co.’s attempt for accelerated approval for its Alzheimer’s therapy donanemab because not enough patients in the trial had received the drug for a full year. The company said the FDA did not...
by Jordana Choucair | Jan 20, 2023 | Mental Health
The new 988 national mental health crisis line has seen a significant rise in call volume since its transition six months ago from the former 1-800-273-TALK number. A CNN analysis shows that more than two million calls, texts, and chats to 988 have been routed to a...
by Jordana Choucair | Jan 20, 2023 | Opioid/Substance Use Disorders
New data from the Centers for Disease Control and Prevention (CDC) found that doctors sent patients home with opioids after emergency department (ED) visits about 8 percent of the time in 2019–2020. The latest figures continue a downward trend from about 12 percent in...
by Jordana Choucair | Jan 19, 2023 | Health IT
A new Kaiser Family Foundation (KFF) analysis suggests that expanded use of telehealth services did not lead to significant cost savings early in the COVID-19 pandemic. According to the analysis, 52 percent of mental health therapy claims in 2020 for people with...
by Jordana Choucair | Jan 19, 2023 | Life Sciences
A new report from the Government Accountability Office found that the Department of Health and Human Services’ (HHS) process for monitoring high-risk research on viruses and other agents that can cause pandemics does not meet the standards for effective...
Recent Comments